Brief: Zim Laboratories March-Qtr PAT Falls
22/05/2019 13:19
May 22 (Reuters) - Zim Laboratories Ltd ZIML.BO :
* RECOMMENDED DIVIDEND AT RATE OF 0.50 RUPEES
* MARCH QUARTER PAT 23 MILLION RUPEES VERSUS 77.9 MILLION
RUPEES
YEAR AGO
* MARCH QUARTER REVENUE FROM OPERATIONS 945.9 MILLION RUPEES
VERSUS 715 MILLION RUPEES YEAR AGO
Source text: http://bit.ly/2JYsKHV
Further company coverage: ZIML.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zim Laboratories
See all newsBrief: Zim Laboratories Gets Marketing Authorization For Dabigatran Etexilate Capsules In Italy, Europe
Brief: Zim Laboratories March-Quarter Consol Net Profit 37.4 Mln Rupees
Brief: Zim Laboratories To Consider Fund Raising Via Securities Issuance
Brief: Zim Laboratories Gets Marketing Authorization For Tamsulosin + Dutasteride Capsules In Australia
India's Zim Laboratories up after getting marketing authorization for migraine drug in Australia